Strategies for chemoprevention of liver cancer

European Journal of Cancer Prevention

Volumn 11, Issue SUPPL. 2, 2002, Pages

  Kensler, Thomas W ^a   Egner, Patricia A ^a   Wang, Jin Bing ^a   Zhu, Yuan Rong ^a   Zhang, Bao Chu ^a   Qian, Geng Sun ^a   Kuang, Shuang Yuan ^a   Gange, Stephen J ^a   Jacobson, Lisa P ^a   Muñoz, Alvaro ^a   Groopman, John D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aflatoxin; Biomarkers; Chemoprevention; Chlorophyllin; Clinical trials; Liver cancer; Oltipraz; Phase 2 enzymes

Indexed keywords

ACETYLCYSTEINE; AFLATOXIN; ANTIMUTAGENIC AGENT; CARCINOGEN; CHLOROPHYLL; CYTOCHROME P450 1A2; GLUTATHIONE TRANSFERASE; OLTIPRAZ; ANTINEOPLASTIC AGENT; CHLOROPHYLLIDE; PYRAZINE DERIVATIVE;

CANCER PREVENTION; CLINICAL TRIAL; CONFERENCE PAPER; DETOXIFICATION; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GENOTOXICITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; CHEMOPROPHYLAXIS; FEMALE; FORECASTING; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; PRIMARY PREVENTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; STANDARD;

ANTICARCINOGENIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOPREVENTION; CHLOROPHYLLIDES; CLINICAL TRIALS; FEMALE; FORECASTING; HUMANS; LIVER NEOPLASMS; MALE; PRIMARY PREVENTION; PROGNOSIS; PYRAZINES; RISK ASSESSMENT;

EID: 0036702273     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Bogaards JJ, Verhagen H, Willems MI, van Poppel G, van Bladdern PJ (1994). Consumption of Brussels sprouts results in elevated alpha-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 15: 1073-5.
2. 1. Complex formation with the carcinogen. Chem Res Toxicol 8: 506-14.
3. Breinholt V, Arbogast D, Leveland P, et al. (1999). Chlorophyllin chemoprevention in trout initiated by aflatoxin B1 bath treatment: An evaluation of reduced bioavailability vs. target organ protective mechanisms. Toxicol Appl Pharmacol 158: 141-51.
4. Chang MH, Chen CJ, Lai MS, et al. (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336: 1855-9.
5. Conney AH (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. GHA Clowes Memorial Lecture. Cancer Res 42: 4875-917.
6. 1. A review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutat Res 399: 245-53.
7. Egner PA, Stansbury KH, Snyder EP, Rogers ME, Hintz PA, Kensler TW (2000). Identification and characterization of chlorin e4 ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial. Chem Res Toxicol 13: 900-6.
8. Fahey JW, Zhang Y, Talalay P (1997). Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 94: 10367-72.
9. Gupta E, Olopade OI, Ratain MJ, et al. (1995). Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin Cancer Res 1: 1133-8.
10. Hayes JD, McLellan LI (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radical Res 31: 273-300.
11. Jacobson LP, Zhang BC, Zhu YR, et al. (1997). Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6: 257-65.
12. Kamat JP, Boloor KK, Devasagayam PA (2000). Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta 1487: 113-27.
13. Kelloff GJ, Johnson JR, Crowell JA, et al. (1995). Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol. Biomarkers Prev. 4: 1-10.
14. Kensler TW, Davis EF, Bolton MG (1994). In The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance (eds Eaton DL, Groopman JD); Academic Press, San Diego, pp. 281-306.
15. Kensler TW, Groopman JD, Roebuck BD (1998a). Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man. Mutat Res 402: 165-72.
16. Kensler TW, He X, Otieno M, et al. (1998b). Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev 7: 127-34.
17. Kensler TW, Groopman JD, Sutter TR, Curphey TJ, Roebuck BD (1999). Development of cancer chemopreventive agents: Oltipraz as a paradigm. Chem Res Toxicol 12: 113-26.
18. Kephart JC (1955). Chlorophyllin derivative - Their chemistry, commercial preparation and uses. Econ Bot 9: 3-38.
19. Kwak MK, Egner PA, Dolan PM, et al. (2001). Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res 480: 305-15.
20. Lampe JW, Chen C, Li S, et al. (2000). Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 9: 787-93.
21. 1 metabolism in human hepatocytes in primary culture. Cancer Res 55: 5574-9.
22. Langouët S, Furge LL, Kerriguy N, Nakamura K, Guillouzo A, Guengerich FP. (2000). Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Chem Res Toxicol 13: 245-52.
23. Maxuitenko YY, Curphey TJ, MacMillan DL., Kensler TW, Roebuck BD (1998). Identification of dithiolethiones with better chemopreventive properties than oltipraz. Carcinogenesis 19: 1609-15.
24. Miller EC, Miller JA (1985) Some historical perspectives on the metabolism of xenobiotic chemicals to reactive intermediates. In Bioactivation of Foreign Compounds (ed. Anders MW); Academic Press, New York, pp. 1-28.
25. Negishi T, Rai H, Hayatsu H (1997). Antigenotixic activity of natural chlorophylls. Mutat Res 376: 97-100.
26. O'Dwyer PJ, Szarka CE, Yao KS, et al. (1996). Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J Clin Invest 98: 1210-17.
27. Qian GS, Ross RK, Yu MC, et al. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3: 3-10.
28. Ross RK, Yuan JM, Yu MC, et al. (1992). Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339: 943-6.
29. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P (2001). Chemoprotective glucosinoates and isothiocyanates of broccoli sprouts: Metabolism and execution in humans. Cancer Epidemiol Biomarkers Prev 10: 501-8.
30. Sofowora GG, Choo EF, Mayo G, Shyr Y, Wilkinson GR (2001). In vivo inhibition of human CYP1A2 activity by oltipraz. Cancer Chemother Pharmacol 47: 505-19.
31. Talalay P, Talalay P (2001). The importance of using scientific principles in the development of medicinal agents from plants. Acad Med 76: 238-47.
32. 1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 91: 347-54.
33. Wang LY, Hatch M, Chen CJ, et al. (1996). Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 67: 620-5.
34. Wilkinson J, IV, Clapper ML (1997). Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med 216: 192-200.
35. Young RW, Bergei JS (1980). Use of chlorophyllin in the care of geriattic patients. J Am Geriat Soc 24: 46-7.
36. Yu SZ (1995). Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 10: 674-82.
37. Yun CY, Hye GJ, Jhoun JW, Guengerich FP (1995). Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis 16: 1437-40.
38. Zhang Y, Talalay P, Cho CG, Posner GH (1992). A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc Natl Acad Sci USA 89: 2399-403.
39. Zhang Y, Kensler T, Cho CG, Posner GH, Talalay P (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91: 3147-50.
40. Zhu YR, Chen JG, Huang XY (1989). Hepatocellular carcinoma in Qidong County. In Primary Liver Cancer (ed. Tang ZY): Springer Verlag, Beijing, pp. 204-22.